These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 6223045)
1. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. Lobo RA; Goebelsmann U; Horton R J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045 [TBL] [Abstract][Full Text] [Related]
2. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. Rittmaster RS; Thompson DL J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885 [TBL] [Abstract][Full Text] [Related]
3. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome. Matteri RK; Stanczyk FZ; Gentzschein EE; Delgado C; Lobo RA Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1704-9. PubMed ID: 2532471 [TBL] [Abstract][Full Text] [Related]
4. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects. Meczekalski B; Slopien R; Warenik-Szymankiewicz A Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812 [TBL] [Abstract][Full Text] [Related]
11. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women. Stanczyk FZ; Saxena T; Lobo RA J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067 [TBL] [Abstract][Full Text] [Related]
12. Disturbances of androgen secretion and metabolism in polycystic ovary syndrome. Lobo RA Clin Obstet Gynaecol; 1985 Sep; 12(3):633-47. PubMed ID: 2933204 [TBL] [Abstract][Full Text] [Related]
13. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels. Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633 [TBL] [Abstract][Full Text] [Related]
15. [Determination of plasma 5 alpha-androstane-3 alpha, 17 beta-diol in the hirsute woman. A critical study of the biological diagnosis of hyperandrogenism]. Heim J; Massart C Nouv Presse Med; 1982 Nov; 11(47):3495-9. PubMed ID: 6218480 [TBL] [Abstract][Full Text] [Related]
16. Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women. Greep N; Hoopes M; Horton R J Clin Endocrinol Metab; 1986 Jan; 62(1):22-7. PubMed ID: 3940268 [TBL] [Abstract][Full Text] [Related]
17. Is 3 alpha-androstanediol a marker of peripheral hirsutism? Toscano V; Sciarra F; Adamo MV; Petrangeli E; Foli S; Caiola S; Conti C Acta Endocrinol (Copenh); 1982 Feb; 99(2):314-20. PubMed ID: 6460409 [TBL] [Abstract][Full Text] [Related]
18. Effect of short- and long-term dexamethasone on 3 alpha-androstanediol glucuronide in hirsute women. Meikle AW; Odell WD Fertil Steril; 1986 Aug; 46(2):227-31. PubMed ID: 3015694 [TBL] [Abstract][Full Text] [Related]
19. Effect of human pituitary luteinizing hormone administration on plasma levels of dehydroepiandrosterone, androstenediol and their sulphates and testosterone in women with secondary amenorrhoea. Sirinathsinghji DJ; Mills IH J Endocrinol; 1983 Aug; 98(2):201-10. PubMed ID: 6223967 [TBL] [Abstract][Full Text] [Related]
20. Evidence for reduced 3 beta-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome. Lobo RA; Goebelsmann U J Clin Endocrinol Metab; 1981 Aug; 53(2):394-400. PubMed ID: 6265489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]